Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 27, 2014, 112 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $347.00 to $12,590,905.04.

Highlighted Stocks Traded by Insiders:

EXCO Resources (XCO) - FREE Research Report

Burnett Richard Alan, who is VP & Chief Accounting Officer at EXCO Resources, bought 690 shares at $5.07 on May 27, 2014. Following this transaction, the VP & Chief Accounting Officer owned 88,500 shares meaning that the stake was boosted by 0.79% with the 690-share transaction.

The shares most recently traded at $5.36, up $0.29, or 5.41% since the insider transaction. Historical insider transactions for EXCO Resources go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 2.0 million
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 4.3 million
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 4.3 million

The average volume for EXCO Resources has been 5.8 million shares per day over the past 30 days. EXCO Resources has a market cap of $1.4 billion and is part of the basic materials sector and energy industry. Shares are down 0.94% year-to-date as of the close of trading on Tuesday.

EXCO Resources, Inc., an independent oil and natural gas company, is engaged in the acquisition, exploration, exploitation, development, and production of onshore oil and natural gas properties with a focus on shale resource plays in the United States. The stock currently has a dividend yield of 3.93%. Currently, there are no analysts who rate EXCO Resources a buy, 4 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XCO - FREE

TheStreet Quant Ratings

rates EXCO Resources as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and a generally disappointing performance in the stock itself. Get the full

EXCO Resources Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Thoratec (THOR) - FREE Research Report

Dimick Neil F, who is Director at Thoratec, sold 4,158 shares at $32.15 on May 27, 2014. Following this transaction, the Director owned 40,953 shares meaning that the stake was reduced by 9.22% with the 4,158-share transaction.

The shares most recently traded at $32.52, up $0.37, or 1.15% since the insider transaction. Historical insider transactions for Thoratec go as follows:

  • 4-Week # shares sold: 6,023
  • 12-Week # shares sold: 19,566
  • 24-Week # shares sold: 27,566

The average volume for Thoratec has been 634,200 shares per day over the past 30 days. Thoratec has a market cap of $1.8 billion and is part of the health care sector and health services industry. Shares are down 11.89% year-to-date as of the close of trading on Tuesday.

Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company has a P/E ratio of 25.2. Currently, there are 10 analysts who rate Thoratec a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THOR - FREE

TheStreet Quant Ratings

rates Thoratec as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full

Thoratec Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Intuit (INTU) - FREE Research Report

Goodarzi Sasan K, who is SVP, Consumer Tax Group at Intuit, sold 2,111 shares at $78.25 on May 27, 2014. Following this transaction, the SVP, Consumer Tax Group owned 3,179 shares meaning that the stake was reduced by 39.91% with the 2,111-share transaction.

The shares most recently traded at $79.37, up $1.12, or 1.4% since the insider transaction. Historical insider transactions for Intuit go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 6,000
  • 24-Week # shares sold: 14,226

The average volume for Intuit has been 1.8 million shares per day over the past 30 days. Intuit has a market cap of $22.6 billion and is part of the technology sector and computer software & services industry. Shares are up 4.28% year-to-date as of the close of trading on Tuesday.

Intuit Inc. provides business and financial management solutions for small businesses, consumers, and accounting professionals in the United States, Canada, the United Kingdom, Australia, India, and Singapore. The stock currently has a dividend yield of 0.95%. The company has a P/E ratio of 27.4. Currently, there are 7 analysts who rate Intuit a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on INTU - FREE

TheStreet Quant Ratings

rates Intuit as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Intuit Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null